Selected article for: "probe primer and real time"

Author: Yosuke Hirotsu; Hitoshi Mochizuki; Masao Omata
Title: Double-Quencher Probes Improved the Detection Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by One-Step RT-PCR
  • Document date: 2020_3_20
  • ID: 2gokv7id_2
    Snippet: Human transmission of SARS-CoV-2 has become a global health concern. The molecular diagnosis of SARS-CoV-2 is highly prioritized to establish the prevention of the viral outbreak and treatment of infected patients. Therefore, demands in detecting the virus in suspected patients in hospitals and clinical laboratories are growing. The Japanese government announced the approval of real-time PCR analysis to detect SARS-CoV-2 for health insurance on M.....
    Document: Human transmission of SARS-CoV-2 has become a global health concern. The molecular diagnosis of SARS-CoV-2 is highly prioritized to establish the prevention of the viral outbreak and treatment of infected patients. Therefore, demands in detecting the virus in suspected patients in hospitals and clinical laboratories are growing. The Japanese government announced the approval of real-time PCR analysis to detect SARS-CoV-2 for health insurance on March 6, 2020. Here, we compared the detection sensitivity among the primer/probe sets designed by the National Institute of Infectious Diseases (NIID) in Japan and the Centers for Disease Control and Prevention (CDC) in the United States of America. These probes were designed as single-quencher probes. We originally designed the double-quencher probes consisting of the same nucleotide sequencing imposed by the NIID. The results showed that double-quenching probes reduced the background signal and improved the detection sensitivity of SARS-CoV-2.

    Search related documents:
    Co phrase search for related documents
    • background signal and detection sensitivity: 1, 2, 3, 4, 5, 6, 7, 8
    • background signal and double quencher: 1, 2, 3, 4, 5, 6, 7, 8
    • background signal and double quencher probe: 1, 2
    • background signal and human transmission: 1
    • background signal reduce and detection sensitivity: 1, 2
    • background signal reduce and double quencher: 1, 2, 3
    • clinical laboratory and detection sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical laboratory and double quencher: 1
    • clinical laboratory and global health concern: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • clinical laboratory and health concern: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical laboratory and health insurance: 1, 2, 3, 4
    • clinical laboratory and human transmission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical laboratory and infected patient: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • clinical laboratory and japanese government: 1
    • clinical laboratory and molecular diagnosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical laboratory hospital and global health concern: 1
    • clinical laboratory hospital and health concern: 1
    • clinical laboratory hospital and human transmission: 1
    • detection sensitivity and molecular diagnosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21